TGTX-109

N/A

Report date: 2024/06/03 12:01:07

Base Information

Drug NameTGTX-109
Drug Alias NameTGTX 109TGTX-109
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsMetabolism, Inborn Errors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesTaysha Gene Therapies Inc
Inactive CompaniesN/A
Active IndicationsMetabolism, Inborn Errors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A